Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Tersedia dari:

Hospira Australia Pty Ltd

INN (Nama Internasional):

Vinorelbine tartrate

Bentuk farmasi:

Injection

Komposisi:

Excipient Ingredients: water for injections

Rute administrasi :

Intravenous

Unit dalam paket:

1 X 5 mL

Kelas:

Medicine Listed (Export Only)

Jenis Resep:

Not scheduled. Not considered by committee

Indikasi Terapi:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.

Ringkasan produk:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status otorisasi:

Licence status A

Tanggal Otorisasi:

2008-05-21